Drug distributor Kyungdongsa on the 1st appointed Ha Hyo-seok, former head of sales at Zuellig Pharma with 28 years of experience in pharmaceutical sales and marketing, as its new CEO. The company plans to boost sales power while accelerating distribution efficiency based on the large logistics center that opened last year.
Ha began a career in the pharmaceutical industry in 1998 as a medical representative (MR) at Korea Boehringer Ingelheim. He then built broad experience across pharmaceutical sales and marketing, including product management (PM), marketing, and sales management.
After joining Zuellig Pharma in 2015, he held key roles in marketing and sales for ethical drugs (ETC). Until recently, he led sales in Zuellig Pharma's Commercial Division, driving commercialization and sales of domestic pharmaceutical companies' products.
Kyungdongsa plans to strengthen client companies' sales capabilities and enhance logistics competitiveness based on Ha's sales experience in the pharmaceutical industry. In particular, it will streamline the pharmaceutical supply chain using the logistics base established last year to bolster distribution capacity not only in the Seoul metropolitan area but nationwide.
Kyungdongsa is a drug distribution company founded in 1972. It has focused on distribution efficiency by adopting automated pharmaceutical logistics systems.
Last year, it integrated logistics bases previously split between Seoul and Suwon into the "KDS Metro Hub" in Dongtan, Hwaseong, Gyeonggi Province. The logistics center covers about 1,500 pyeong. Under the new CEO, Kyungdongsa plans to advance its logistics network for the Seoul metropolitan area and nationwide with the Metro Hub at the center.
Ha said, "We will combine the logistics infrastructure and sales capabilities Kyungdongsa has built to improve the stability of pharmaceutical supply and the efficiency of distribution," adding, "We will go beyond drug distribution to create services that customers and medical sites can feel, strengthening our competitiveness."